Completed PHASE3 INTERVENTIONAL 2-arm NCT01798680

Trial of Vitamin D in HIV Progression (TOV4)

Sponsor: Harvard School of Public Health (HSPH)

Interventions Placebo Vitamin D3 (cholecalciferol)

Updated 10 times since 2017 Last updated: Aug 8, 2019 Started: Feb 28, 2014 Primary completion: Mar 31, 2018 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates HIV Infection and is currently completed. Harvard School of Public Health (HSPH) leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jan 2022 [monthly]

Completed PHASE3
Sep 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed

▶ Show 5 earlier versions

May 2019 — Sep 2019 [monthly]

Active Not Recruiting PHASE3
Jun 2018 — May 2019 [monthly]

Active Not Recruiting PHASE3
May 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE3
Apr 2017 — May 2018 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Jan 2017 — Apr 2017 [monthly]

Recruiting PHASE3

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Harvard School of Public Health (HSPH)
Management and Development for Health (MDH)

Data source: Harvard School of Public Health (HSPH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dar es Salaam, Tanzania